(Q41915254)

14 October 2017

Intracellular efavirenz levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals (English)

1 reference

14 October 2017

1 reference

Rie Tanaka

1

1 reference

14 October 2017

Hideji Hanabusa

2

1 reference

14 October 2017

Ei Kinai

3

1 reference

14 October 2017

Naoki Hasegawa

4

1 reference

14 October 2017

Masayoshi Negishi

5

1 reference

14 October 2017

Shingo Kato

6

1 reference

14 October 2017

language of work or name

English

0 references

publication date

10 December 2007

1 reference

Antimicrobial Agents and Chemotherapy

14 October 2017

1 reference

14 October 2017

52

1 reference

14 October 2017

2

1 reference

14 October 2017

782-785

1 reference

The intracellular pharmacology of antiretroviral protease inhibitors

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Intracellular accumulation of human immunodeficiency virus protease inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224777

18 August 2018

Identifiers

DOI

10.1128/AAC.01613-06

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

18070970

1 reference